Recent developments in clinical trials of botulinum neurotoxins

Alberto Albanese, Antoniangela Cocco

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

4 Citazioni (Scopus)

Abstract

Botulinum neurotoxins (BoNTs) are increasingly used in clinical practice for several indications. Following the pioneering years of discoveries, the recent years have witnessed an increase of new indications and new toxin brands.We review here the clinical trials on BoNTs performed since 2014 and put them into perspective. We also review the ongoing trials listed by the National Institutes of Health registry (Clinicaltrials.gov). The following indications are reviewed here: blepharospasm, cervical dystonia, spasticity, cerebral palsy, urinary incontinence, headache, topical formulations, postoperative cardiac arrhythmia, keloids and scars. For each of these indications the latest trials are reviewed and commented.
Lingua originaleEnglish
pagine (da-a)1-8
Numero di pagine8
RivistaToxicon
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Botulinum toxins
  • Clinical trial
  • Toxicology

Fingerprint

Entra nei temi di ricerca di 'Recent developments in clinical trials of botulinum neurotoxins'. Insieme formano una fingerprint unica.

Cita questo